Responsive morphometric fingerprints in deep brain stimulation for Parkinson’s disease
Objective: In this study, we identified differential network characteristics based on graph theory of structural covariance network (SCN) between responders and non-responders of DBS. Background:…The impact of Deep Brain Stimulation for Parkinson’s disease on Quality of Life
Objective: To evaluate the long-term outcomes in Quality of Life (QoL) for patients with Parkinson’s disease (PwP) enrolled in a global, real-world device registry for…Comparison of two methods of deep brain stimulation lead reconstruction and their prediction capacities
Objective: The study evaluates the prediction capacity of two different Deep brain stimulation (DBS) electrode reconstructions methods: Lead-DBS and StimView . The methods predictions of…Time To Access Deep Brain Stimulation Surgery for Movement Disorders: A Canadian Single Center Study
Objective: To assess barriers to accessing Deep Brain Stimulation (DBS), as a function of the time required for each step of the workup and how…Assessment of Image-Guided Programming (IGP) in Bilateral STN and GPi Deep Brain Stimulation on Programming Time and Setting Outcomes
Objective: We describe assessment of Parkinson's disease (PD) patient outcomes using an image-guided programming (IGP) tool as conducted during initial Deep Brain Stimulation (DBS) programming,…Prolonged Positive Response: Subthalamic Nucleus as a Deep Brain Stimulation Target in X-linked Dystonia-Parkinsonism
Objective: To demonstrate long-term improvement of parkinsonism and dystonia in patients with X-linked dystonia-parkinsonism (XDP) following deep brain stimulation (DBS) in the subthalamic nucleus (STN).…Cognitive Outcome in Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deep Brain Stimulation (DBS):Case Report
Objective: To assess cognitive outcome in PKAN treated with DBS Background: PKAN is a rare neurodegenerative disorder with pediatric onset & dystonic features. Motor symptoms…Cerebrovascular Reactivity and Glymphatic Clearance in Parkinson’s disease
Objective: To evaluate whether altered cerebrovascular reactivity contributes to reduced glymphatic clearance in Parkinson’s disease (PD). Background: Cerebrovascular activity is a major factor driving cerebrospinal…Repurposing Anti-Gout Medications for the Treatment of Parkinson’s Disease
Objective: To undertake a repurposing drug screen for Parkinson’s disease (PD) and further investigate the mechanism of action of top hits. To assess, in vivo,…Differential Symptom Cluster Responses and Predictors to Repetitive Transcranial Magnetic Stimulation Treatment in Parkinson’s Disease：A Retrospective Study
Objective: This study aimed to investigate the related factors for the response to rTMS in PD patients. Background: Repetitive transcranial magnetic stimulation (rTMS) is an…
- « Previous Page
- 1
- …
- 443
- 444
- 445
- 446
- 447
- …
- 1942
- Next Page »